147 related articles for article (PubMed ID: 31956087)
1. Metastatic melanoma: Surgical treatment of brain metastases - Analysis of 110 patients.
McHugh FA; Kow CY; Falkov A; Heppner P; Law A; Bok A; Schweder P
J Clin Neurosci; 2020 Mar; 73():144-149. PubMed ID: 31956087
[TBL] [Abstract][Full Text] [Related]
2. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control.
Alvarez-Breckenridge C; Giobbie-Hurder A; Gill CM; Bertalan M; Stocking J; Kaplan A; Nayyar N; Lawrence DP; Flaherty KT; Shih HA; Oh K; Batchelor TT; Cahill DP; Sullivan R; Brastianos PK
Oncologist; 2019 May; 24(5):671-679. PubMed ID: 30796152
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients.
Wroński M; Arbit E
J Neurosurg; 2000 Jul; 93(1):9-18. PubMed ID: 10883899
[TBL] [Abstract][Full Text] [Related]
4. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome.
Panagiotou IE; Brountzos EN; Kelekis DA; Papathanasiou MA; Bafaloukos DI
Neoplasma; 2005; 52(2):150-8. PubMed ID: 15800714
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the outcome after treatment for metastatic melanoma to the brain.
Carrubba CJ; Vitaz TW
Surg Neurol; 2009 Dec; 72(6):707-11. PubMed ID: 19604550
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Amaria RN; Prieto PA; Tetzlaff MT; Reuben A; Andrews MC; Ross MI; Glitza IC; Cormier J; Hwu WJ; Tawbi HA; Patel SP; Lee JE; Gershenwald JE; Spencer CN; Gopalakrishnan V; Bassett R; Simpson L; Mouton R; Hudgens CW; Zhao L; Zhu H; Cooper ZA; Wani K; Lazar A; Hwu P; Diab A; Wong MK; McQuade JL; Royal R; Lucci A; Burton EM; Reddy S; Sharma P; Allison J; Futreal PA; Woodman SE; Davies MA; Wargo JA
Lancet Oncol; 2018 Feb; 19(2):181-193. PubMed ID: 29361468
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in malignant melanoma patients with solitary or multiple brain metastases. Is there a role for surgery?
Konstadoulakis MM; Messaris E; Zografos G; Androulakis G; Karakousis C
J Neurosurg Sci; 2000 Dec; 44(4):211-8; discussion 219. PubMed ID: 11327290
[TBL] [Abstract][Full Text] [Related]
8. Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications.
Lavine SD; Petrovich Z; Cohen-Gadol AA; Masri LS; Morton DL; O'Day SJ; Essner R; Zelman V; Yu C; Luxton G; Apuzzo ML
Neurosurgery; 1999 Jan; 44(1):59-64; discussion 64-6. PubMed ID: 9894964
[TBL] [Abstract][Full Text] [Related]
9. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades.
Zacest AC; Besser M; Stevens G; Thompson JF; McCarthy WH; Culjak G
J Neurosurg; 2002 Mar; 96(3):552-8. PubMed ID: 11883841
[TBL] [Abstract][Full Text] [Related]
11. Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
Frinton E; Tong D; Tan J; Read G; Kumar V; Kennedy S; Lim C; Board RE
J Neurooncol; 2017 Dec; 135(3):507-512. PubMed ID: 28819707
[TBL] [Abstract][Full Text] [Related]
12. Intracerebral metastases of malignant melanoma and their recurrences--a clinical analysis.
Miller D; Zappala V; El Hindy N; Livingstone E; Schadendorf D; Sure U; Sandalcioglu IE
Clin Neurol Neurosurg; 2013 Sep; 115(9):1721-8. PubMed ID: 23643143
[TBL] [Abstract][Full Text] [Related]
13. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment.
Ly D; Bagshaw HP; Anker CJ; Tward JD; Grossmann KF; Jensen RL; Shrieve DC
J Neurosurg; 2015 Aug; 123(2):395-401. PubMed ID: 25768829
[TBL] [Abstract][Full Text] [Related]
14. Survival and prognostic factors in patients with brain metastases from malignant melanoma.
Meier S; Baumert BG; Maier T; Wellis G; Burg G; Seifert B; Dummer R
Onkologie; 2004 Apr; 27(2):145-9. PubMed ID: 15138346
[TBL] [Abstract][Full Text] [Related]
15. Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.
Milsch L; Gesierich A; Kreft S; Livingstone E; Zimmer L; Goebeler M; Schadendorf D; Schilling B
Eur J Cancer; 2018 Aug; 99():58-65. PubMed ID: 29906735
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.
Sperduto PW; Jiang W; Brown PD; Braunstein S; Sneed P; Wattson DA; Shih HA; Bangdiwala A; Shanley R; Lockney NA; Beal K; Lou E; Amatruda T; Sperduto WA; Kirkpatrick JP; Yeh N; Gaspar LE; Molitoris JK; Masucci L; Roberge D; Yu J; Chiang V; Mehta M
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1069-1077. PubMed ID: 28721890
[TBL] [Abstract][Full Text] [Related]
17. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
[TBL] [Abstract][Full Text] [Related]
19. Surgery and adjuvant therapies in the treatment of stage IV melanoma: our experience in 84 patients.
Tauceri F; Mura G; Roseano M; Framarini M; Ridolfi L; Verdecchia GM
Langenbecks Arch Surg; 2009 Nov; 394(6):1079-84. PubMed ID: 18317795
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of melanoma brain metastases in patients treated with immunotherapy.
Lonser RR; Song DK; Klapper J; Hagan M; Auh S; Kerr PB; Citrin DE; Heiss JD; Camphausen K; Rosenberg SA
J Neurosurg; 2011 Jul; 115(1):30-6. PubMed ID: 21476810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
